Drug makers may profit from disease in global warming scourge

authordefault
on

A report by PricewaterhouseCoopers LLP forecast that higher temperatures could lead to a doubling of the world pharmaceutical market in 13 years , with sales of medicines increasing to $1.3 trillion US from about $600 billion last year – provided drug makers find innovative treatments.

The New York-based accounting and consulting company, citing the Intergovernmental Panel on Climate Change, said the average temperature is projected to increase by 0.4 degrees Celsius during the next two decades and the increase could be greater if greenhouse-gas emissions increase.

Climate change may already be playing a role in reports of malaria in countries such as Turkey and Georgia where it was eradicated, the report said.

Related Posts

on

Proposed legislation would further lower regulatory hurdles, despite environmental and public health risks.

Proposed legislation would further lower regulatory hurdles, despite environmental and public health risks.
on

Insiders aren’t surprised as ExxonMobil, the last remaining proponent of green algae biofuel, ends research.

Insiders aren’t surprised as ExxonMobil, the last remaining proponent of green algae biofuel, ends research.
on

Bayer’s efforts to sway public opinion are part of a strategy to “fight any sustainable transition which would harm its business”, say campaigners.

Bayer’s efforts to sway public opinion are part of a strategy to “fight any sustainable transition which would harm its business”, say campaigners.
Opinion
on

Greece’s worst rail disaster ever is the result of the same corporate cost-cutting and deregulation that led to East Palestine and Lac-Mégantic disasters.

Greece’s worst rail disaster ever is the result of the same corporate cost-cutting and deregulation that led to East Palestine and Lac-Mégantic disasters.